Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab

A Martens, K Wistuba-Hamprecht, MG Foppen… - Clinical Cancer …, 2016 - AACR
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome
following ipilimumab treatment in advanced melanoma patients. Experimental Design …
被引用次数：562 相关文章

[引用][C] Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab

A Martens, K Wistuba-Hamprecht… - Clinical Cancer …, 2016 - ub01.uni-tuebingen.de
Baseline peripheral blood biomarkers associated with clinical outcome of advanced
melanoma patients treated with ipilimumab Baseline peripheral blood biomarkers …

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

AA Martens, KK Wistuba-Hamprecht… - Clinical Cancer …, 2016 - hal.science
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome
following ipilimumab treatment in advanced melanoma patients. Experimental Design …
[HTML] nih.gov

[HTML][HTML] Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab

A Martens, K Wistuba-Hamprecht… - … cancer research: an …, 2016 - ncbi.nlm.nih.gov
Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma
patients treated with ipilimumab - PMC Back to Top Skip to main content NIH NLM Logo Access …

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

A Martens, K Wistuba-Hamprecht, MG Foppen… - Clinical Cancer …, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: To identify baseline peripheral blood
biomarkers associated with clinical outcome following ipilimumab treatment in advanced …

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.

A Martens, K Wistuba-Hamprecht, J Yuan… - … Cancer Research: an …, 2016 - europepmc.org
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma
Patients Treated with Ipilimumab. - Abstract - Europe PMC Sign in | Create an account …

[引用][C] Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab

A Martens, K Wistuba-Hamprecht… - Clinical Cancer …, 2016 - tobias-lib.ub.uni-tuebingen.de
Baseline peripheral blood biomarkers associated with clinical outcome of advanced
melanoma patients treated with ipilimumab Baseline peripheral blood biomarkers …

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

AA Martens, KK Wistuba-Hamprecht… - Clinical Cancer …, 2016 - inserm.hal.science
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome
following ipilimumab treatment in advanced melanoma patients. Experimental Design …
[PDF] universiteitleiden.nl

[PDF][PDF] Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab

A Martens… - Clinical …, 2018 - scholarlypublications …
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome
following ipilimumab treatment in advanced melanoma patients. experimental design …

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

A Martens, K Wistuba-Hamprecht… - … : an official journal …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose To identify baseline peripheral blood biomarkers associated with clinical outcome
following ipilimumab treatment in advanced melanoma patients. Experimental design …